-transparent.png){kind=logo}
The effect of somatostatin (0.05 and 1.5 micrograms/kg/hr) and of thyrotropin-releasing hormone (0.1 and 1.0 microgram/kg/hr) on cholecystokinin-induced gallbladder emptying was studied in healthy volunteers by means of real-time ultrasonography. In addition, the action of increasing doses (0.05, 0.15, 0.45, and 1.35 micrograms/kg/hr) of somatostatin on resting gallbladder volume was also evaluated. Somatostatin, at the dose of 0.05 microgram/kg/hr (shown to produce blood levels similar to those measured after a meal) significantly inhibited the gallbladder contraction in response to cholecystokinin. Kinetic analysis showed that the interaction of somatostatin and cholecystokinin is of the noncompetitive type. The higher dose of the peptide (1.5 microgram/kg/hr) completely suppressed cholecystokinin-induced gallbladder contraction. In experiments carried out using somatostatin alone, a progressive increase in gallbladder volume in response to increasing doses of peptide was observed. The administration of either dose of thyrotropin-releasing hormone did not affect gallbladder emptying in any of the subjects studied. It is concluded that somatostatin is a potent inhibitor of cholecystokinin action on the gallbladder. The clear effectiveness of a very low, presumably physiological, dose indicates that somatostatin may play a physiological role in the regulation of gallbladder motor activity and provides further evidence that the peptide may act as a true hormone in man. Thyrotropin-releasing hormone does not seem to affect gallbladder motility, at least under the experimental conditions of the present study.
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
January 1982,
The Japanese journal of physiology,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
February 1979,
The American journal of clinical nutrition,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
April 1976,
Pharmacology, biochemistry, and behavior,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
July 1992,
Psychiatry research,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
July 1999,
The American journal of gastroenterology,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
November 2012,
Regulatory peptides,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
January 1998,
Hepato-gastroenterology,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
January 1992,
Digestive diseases and sciences,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
January 1987,
Neurochemical research,
L Gullo, and
L Bolondi, and
C Scarpignato, and
P Priori, and
P Casanova, and
G Labò
June 1988,
No to shinkei = Brain and nerve,
